Hepatitis C in Primary Care and Drug and Alcohol Settings Education Program

July 18

Hepatitis C in Primary Care and Drug and Alcohol Settings Education Program

People who inject drugs (PWID) represent approximately 90% of newly acquired hepatitis C (HCV) infections. Clinicians working with PWID play an important role in reducing HCV-related morbidity and mortality through early diagnosis and treatment. With the advent of new, well-tolerated, short-course direct-acting antiviral (DAA) HCV regimens with cure rates >95%, there is an opportunity to vastly improve the health outcomes of people living with HCV.

This course is designed for addiction medicine specialists, family physicians and other medical staff working with people who inject drugs. Through online learning and a face-to-face workshop, delivered by local experts, participants will gain the skills to confidently manage hepatitis C in their setting.

By the end of this program, participants will be able to:

  • Describe the risk factors for HCV infection, enabling effective practice screening processes and prevention education
  • Demonstrate competence interpreting clinical information to effectively diagnose HCV
  • Demonstrate competence in liver disease assessment
  • Demonstrate understanding of DAA therapy for the treatment of HCV and competence in selecting and prescribing appropriate therapy
  • Monitor patients on treatment and post-treatment appropriately

Date: Sunday, 28 October 2018

Time: 8:30am – 4:00pm

Location: Fairmont Hotel Vancouver 900 West Georgia Street Vancouver, BC, V6C 2W6

Cost: Free of charge, catering provided. Places are limited – registration is essential.

Register: https://ashm.eventsair.com/inhsu/hcvworkshopvancouver281018/Site/Register

Open to both delegates from the CSAM Meeting and local practitioners. For further information or to inquire about travel scholarships, please contact info@inhsu.org.

This event is an Accredited Group Learning Activity (Section 1) as defined by the Maintenance of Certification program of The Royal College of Physicians and Surgeons of Canada, and accredited by the Canadian Association for the Study of the Liver. Participants can claim up to a maximum of 6.0 study credits.

This Group Learning program has also been reviewed by the College of Family Physicians of Canada and is awaiting final certification by the College’s BC Chapter.

The workshop is convened by the International Network on Hepatitis in Substance Users (INHSU), an international organization dedicated to scientific knowledge exchange, knowledge translation, and advocacy focused on hepatitis C prevention and care among people who use drugs. http://inhsu.org/

This course has been funded through an unrestricted grant from Gilead Sciences Canada Inc. Gilead has had no input into the tone, content or emphasis of the material used at this course.

Download Flyer


Posted in: Uncategorized

« Previous PostNext Post »